Friederike Maechler
Overview
Explore the profile of Friederike Maechler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saydan S, Schwab F, Holstiege J, Batzing J, Behnke M, Schneider S, et al.
J Antimicrob Chemother
. 2025 Jan;
80(3):817-824.
PMID: 39821312
Background: Antibiotic consumption is considered an important risk factor for Clostridioides difficile infection (CDI). This ecological analysis investigates the influence of outpatient antibiotic prescriptions in statutory health insurance (SHI) on...
2.
Hackmann C, Genath A, Gruhl D, Weber A, Maechler F, Kola A, et al.
Euro Surveill
. 2024 Sep;
29(39).
PMID: 39328155
BackgroundCarriage of multidrug-resistant organisms (MDROs) in humans constitutes an important public health concern. Cross-transmission of bacteria between animals and humans has been demonstrated before.AimOur aim was to quantify the risk...
3.
Genath A, Hackmann C, Denkel L, Weber A, Maechler F, Kola A, et al.
Antimicrob Resist Infect Control
. 2024 Sep;
13(1):107.
PMID: 39304920
Introduction: The global increase of multidrug-resistant organisms (MDROs) is one of the most urgent public health threats affecting both humans and animals. The One Health concept emphasizes the interconnectedness of...
4.
Thieme A, Gertler M, Piening B, Maechler F, Benzler J, Hartmann C, et al.
Sci Rep
. 2023 Dec;
13(1):22498.
PMID: 38110426
During the SARS-CoV-2 pandemic, the German healthcare system faced challenges of efficiently allocating testing resources. To address this, we developed an open-source personalized recommendation system (PRS) called "CovApp". The PRS...
5.
Wiese-Posselt M, Saydan S, Schwab F, Behnke M, Kola A, Kramer T, et al.
Dtsch Arztebl Int
. 2023 May;
120(26):447-453.
PMID: 37199029
Background: Methicillin-resistant Staphylococcus aureus (MRSA) has become less common in Germany in recent years. In this paper, we report data from the MRSA module of the Hospital Infection Surveillance System...
6.
Maechler F, Schwab F, Hansen S, Behnke M, Bonten M, Canton R, et al.
Infect Control Hosp Epidemiol
. 2023 Mar;
44(9):1410-1416.
PMID: 36912321
Objectives: The aim of this study was to quantify the time delay between screening and initiation of contact isolation for carriers of extended-spectrum beta-lactamase (ESBL)-producing Enterobacterales (ESBL-E). Methods: This study...
7.
Brestrich G, Angulo F, Berger F, Brosamle C, Hagel S, Leischker A, et al.
Infect Dis Ther
. 2023 Mar;
12(4):1057-1072.
PMID: 36897556
Introduction: Clostridioides difficile infection (CDI) is a recognized global threat especially for vulnerable populations. It is of particular concern to healthcare providers as it is found in both hospital and...
8.
Maechler F, Weber A, Schwengers O, Schwab F, Denkel L, Behnke M, et al.
Microb Genom
. 2023 Feb;
9(1).
PMID: 36748706
The increase of Vancomycin-resistant (VREfm) in recent years has been partially attributed to the rise of specific clonal lineages, which have been identified throughout Germany. To date, there is no...
9.
Ginter K, Schwab F, Behnke M, Wolkewitz M, Gastmeier P, Geffers C, et al.
Infection
. 2023 Jan;
51(4):993-1001.
PMID: 36637773
Purpose: Early identification of high-risk patients is an important component in improving infection prevention. The SAPS2, APACHE2, Core-10-TISS, and SOFA scores are already widely used to estimate mortality, morbidity and...
10.
Meyer F, Fritz A, Deng Z, Koslicki D, Lesker T, Gurevich A, et al.
Nat Methods
. 2022 Apr;
19(4):429-440.
PMID: 35396482
Evaluating metagenomic software is key for optimizing metagenome interpretation and focus of the Initiative for the Critical Assessment of Metagenome Interpretation (CAMI). The CAMI II challenge engaged the community to...